Health Canada approves Dexcom G7 Continuous Glucose Monitoring System for people with all types of diabetes
Dexcom, Inc., a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, announced that Health Canada has approved the next-generation Dexcom G7 Continuous Glucose Monitoring System for people with all types of diabetes, ages two years and older. Diabetes is a complex and burdensome condition affecting more than 3 million Canadians. It requires around-the-clock management of glucose levels and daily treatment decisions to manage the disease. Health Canada approval of Dexcom G7 gives Canadians access to a game changing technology that makes managing diabetes easier, and has been shown to reduce hospitalizations and emergency room visits due to hypoglycaemia by up to 42 per cent.
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
